Cargando…

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis

BACKGROUND: Lipid profiles appear to be altered in rheumatoid arthritis (RA) patients because of disease activity and inflammation. Cholesterol efflux capacity (CEC), which is the ability of high-density lipoprotein cholesterol to accept cholesterol from macrophages, has been linked not only to card...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tejera-Segura, Beatriz, Macía-Díaz, María, Machado, José David, de Vera-González, Antonia, García-Dopico, Jose A., Olmos, José M., Hernández, José L., Díaz-González, Federico, González-Gay, Miguel A., Ferraz-Amaro, Iván
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452399/ https://www.ncbi.nlm.nih.gov/pubmed/28569219 http://dx.doi.org/10.1186/s13075-017-1311-3

Ejemplares similares

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
por: García-González, María, et al.
Publicado: (2023)

Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients
por: Ferraz-Amaro, Iván, et al.
Publicado: (2013)

Incretins in patients with rheumatoid arthritis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

The Ratio of Monocytes to HDL-Cholesterol Is Associated with Cardiovascular Risk and Insulin Resistance in Patients with Rheumatoid Arthritis
por: Romo-Cordero, Alejandro, et al.
Publicado: (2023)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation
por: Rein, Philipp, et al.
Publicado: (2010)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
por: Srivastava, Neelam, et al.
Publicado: (2018)

Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients
por: López-Mejías, Raquel, et al.
Publicado: (2015)

Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity
por: González-Sierra, Marta, et al.
Publicado: (2023)

Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis
por: Zhou, Mei, et al.
Publicado: (2019)

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis
por: López-Mejías, Raquel, et al.
Publicado: (2017)

A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
por: Xie, Binbin, et al.
Publicado: (2021)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017)

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis
por: López-Mejías, Raquel, et al.
Publicado: (2016)

Uremia alters HDL composition and cholesterol efflux capacity
por: Holzer, Michael, et al.
Publicado: (2012)

HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk
por: Parra, Eliane Soler, et al.
Publicado: (2014)

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
por: de Armas-Rillo, Laura, et al.
Publicado: (2022)

Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux
por: Navdaev, Alexei V., et al.
Publicado: (2020)

Red Cell Distribution Width Association with Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2023)

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015)

Cholesterol efflux pathways, inflammation, and atherosclerosis
por: Groenen, Anouk G., et al.
Publicado: (2021)

HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study
por: Hunjadi, Monika, et al.
Publicado: (2020)

The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2018)

9-cis β-Carotene Increased Cholesterol Efflux to HDL in Macrophages
por: Bechor, Sapir, et al.
Publicado: (2016)

Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
por: Jebari-Benslaiman, Shifa, et al.
Publicado: (2020)

Lower than average HDL cholesterol efflux capacity in Lithuanian population
por: Kutkiene, Sandra, et al.
Publicado: (2019)

Scavenging dicarbonyls with 5′-O-pentyl-pyridoxamine increases HDL net cholesterol efflux capacity and attenuates atherosclerosis and insulin resistance
por: Huang, Jiansheng, et al.
Publicado: (2022)

Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport
por: Ikhlef, Souade, et al.
Publicado: (2017)

Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy
por: Kockx, Maaike, et al.
Publicado: (2022)

Postprandial Hyperlipidemia: Association with Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
por: Mena-Vázquez, Natalia, et al.
Publicado: (2022)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2021)

HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
por: Blanco-Rojo, Ruth, et al.
Publicado: (2017)

Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity
por: Didichenko, Svetlana A., et al.
Publicado: (2016)

Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
por: Paavola, Timo, et al.
Publicado: (2017)

Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis
por: González-Gay, Miguel A, et al.
Publicado: (2012)

Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_31k51bm4i2ks8eu8t1c8uiqnji